Cytokinetics Incorporated (CYTK)

Cytokinetics Incorporated (CYTK $37.23)
- $37.23 Cap: $4.61B
- View CYTK Profile
- View Questions on CYTK

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

AstraZeneca PLC (AZN $68.79)
- $68.79 Fwd P/E: 30.88X Cap: $214.78B
- View AZN Profile
- View Questions on AZN
Cytokinetics Incorporated (CYTK $37.23)
- $37.23 Cap: $4.61B
- View CYTK Profile
- View Questions on CYTK

Q: Hi 5i
Could not find this company in your data base....Looking for opinion on this company...Held shares for a while and see now that share price jumped and then dropped on speculation of potentially being acquired by novartis or amgen ect...

Can you provide any insight into whats is happening with this companies stock and if its worth hanging on...current small position but 2% now with current price increase.

jim

Read Answer Asked by jim on January 19, 2024